PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CURE vs. ICLN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


CUREICLN
YTD Return3.78%-15.03%
1Y Return5.96%-29.12%
3Y Return (Ann)4.07%-17.69%
5Y Return (Ann)16.84%6.69%
10Y Return (Ann)19.04%4.18%
Sharpe Ratio0.23-1.10
Daily Std Dev31.45%25.36%
Max Drawdown-69.19%-87.16%
Current Drawdown-26.56%-65.23%

Correlation

-0.50.00.51.00.5

The correlation between CURE and ICLN is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

CURE vs. ICLN - Performance Comparison

In the year-to-date period, CURE achieves a 3.78% return, which is significantly higher than ICLN's -15.03% return. Over the past 10 years, CURE has outperformed ICLN with an annualized return of 19.04%, while ICLN has yielded a comparatively lower 4.18% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%2,000.00%2,500.00%NovemberDecember2024FebruaryMarchApril
2,204.32%
12.30%
CURE
ICLN

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Direxion Daily Healthcare Bull 3x Shares

iShares Global Clean Energy ETF

CURE vs. ICLN - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than ICLN's 0.46% expense ratio.


CURE
Direxion Daily Healthcare Bull 3x Shares
Expense ratio chart for CURE: current value at 1.08% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.08%
Expense ratio chart for ICLN: current value at 0.46% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.46%

Risk-Adjusted Performance

CURE vs. ICLN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and iShares Global Clean Energy ETF (ICLN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CURE
Sharpe ratio
The chart of Sharpe ratio for CURE, currently valued at 0.23, compared to the broader market-1.000.001.002.003.004.005.000.23
Sortino ratio
The chart of Sortino ratio for CURE, currently valued at 0.54, compared to the broader market-2.000.002.004.006.008.000.54
Omega ratio
The chart of Omega ratio for CURE, currently valued at 1.06, compared to the broader market0.501.001.502.002.501.06
Calmar ratio
The chart of Calmar ratio for CURE, currently valued at 0.15, compared to the broader market0.002.004.006.008.0010.0012.000.15
Martin ratio
The chart of Martin ratio for CURE, currently valued at 0.65, compared to the broader market0.0020.0040.0060.000.65
ICLN
Sharpe ratio
The chart of Sharpe ratio for ICLN, currently valued at -1.10, compared to the broader market-1.000.001.002.003.004.005.00-1.10
Sortino ratio
The chart of Sortino ratio for ICLN, currently valued at -1.68, compared to the broader market-2.000.002.004.006.008.00-1.68
Omega ratio
The chart of Omega ratio for ICLN, currently valued at 0.82, compared to the broader market0.501.001.502.002.500.83
Calmar ratio
The chart of Calmar ratio for ICLN, currently valued at -0.46, compared to the broader market0.002.004.006.008.0010.0012.00-0.46
Martin ratio
The chart of Martin ratio for ICLN, currently valued at -1.30, compared to the broader market0.0020.0040.0060.00-1.30

CURE vs. ICLN - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.23, which is higher than the ICLN Sharpe Ratio of -1.10. The chart below compares the 12-month rolling Sharpe Ratio of CURE and ICLN.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.00NovemberDecember2024FebruaryMarchApril
0.23
-1.10
CURE
ICLN

Dividends

CURE vs. ICLN - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.82%, less than ICLN's 1.87% yield.


TTM20232022202120202019201820172016201520142013
CURE
Direxion Daily Healthcare Bull 3x Shares
1.82%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%0.00%1.24%
ICLN
iShares Global Clean Energy ETF
1.87%1.59%0.89%1.18%0.34%1.36%2.77%2.49%3.88%2.36%2.82%2.10%

Drawdowns

CURE vs. ICLN - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum ICLN drawdown of -87.16%. Use the drawdown chart below to compare losses from any high point for CURE and ICLN. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2024FebruaryMarchApril
-26.56%
-59.01%
CURE
ICLN

Volatility

CURE vs. ICLN - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 10.19% compared to iShares Global Clean Energy ETF (ICLN) at 6.44%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than ICLN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
10.19%
6.44%
CURE
ICLN